论文部分内容阅读
目的观察米非司酮配伍米索前列醇终止≤37d早早孕的临床效果。方法对月经周期规律,停经≤37d,尿人绒毛膜促性腺激素(HCG)阳性(包括弱阳性)或血β-HCG高于参考范围,做检查正常后直接给予米非司酮配伍米索前列醇,观察临床效果,定期随诊,并进行满意度自评。结果101例早早孕妇女中有96例成功,4例因出血多行清宫术,1例为多囊卵巢综合征患者,改用黄体酮月经来潮。结论米非司酮配伍米索前列醇终止≤37d早早孕,效果显著,经济负担轻,不良反应少,患者满意度高。
Objective To observe the clinical efficacy of mifepristone with misoprostol in terminating early pregnancy ≤37 days. Methods Regular menstrual cycle, menopause ≤ 37d, urine HCG positive (including weakly positive) or blood β-HCG higher than the reference range, do a check after normal mifepristone with misoprostol Alcohol, observe the clinical effect, regular follow-up, and satisfaction self-assessment. Results Of the 101 early pregnant women, 96 were successful, 4 were cured by hemorrhage and 1 were polycystic ovary syndrome patients. They switched to progesterone menstruation. Conclusion Mifepristone combined with misoprostol termination early pregnancy ≤ 37d, the effect is significant, the economic burden of light, fewer adverse reactions, patients with high satisfaction.